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Presentation Overview
• Important thoughts before model development 
• Beginning the verification, validation, and credibility 
(VV&C) journey 
• Defining Integrated Medical Model (IMM) framework 
• IMM Compliance Matrix 
• IMM Verification and Validation (V&V) 
• IMM Credibility Scoring 
• Summary 
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Thoughts Before Model Development
• Establishing model and simulation (M&S) credibility 
starts before model development 
• M&S credibility includes modeling team with end user 
and/or customer 
• Successful M&S will have ongoing credibility 
assessments throughout life of model 
  
 
 
“Essentially, all models are wrong, but some are useful.” 
 George Box (1987); Professor Emeritus of Statistics at the  
     University of Wisconsin 
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Guiding VV&C Document Chronology
• Recommended practices references 
• IMM Verification and Validation Plan (2008) 
• NASA-STD-7009 Standard for Models and 
Simulations (2008/2013) 
• NASA-HDBK-7009 Implementation Guide for 
NASA-STD-7009 (2013) 
• NASA-STD-7009 Guidance Document for Human 
Health and Systems Models and Simulations 
(estimated 2014) 
Why IMM? 
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Risk of unacceptable health and mission outcomes due to limitations of in-flight 
medical capabilities. 
Goal: Develop an integrated, quantified, evidence-based probabilistic risk 
forecasting model to be used as a decision support tool for NASA crew health 
and mission planners that can help guide exploration planning, requirements 
development, and R&D technology investment activities. 
Beginning the VV&C Journey
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Real world system (RWS): the most likely health state of the astronaut crew with a 
defined set of medical resources used to diagnose and treat medical events, and most 
likely mission impacts due to medical causes 
Defining IMM Framework
Approach: Employ best-evidence clinical research methods, probabilistic risk 
assessment (PRA) techniques using ISS as a precursor to exploration missions 
ISS baseline: RWS in the context of a microgravity environment in low earth orbit 
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IMM 7009 Compliance 
Compliant Compliance 
Incomplete 
Not Applicable 
37 9 3
49 Requirements 
Near Future 
IMM 7009 Compliance Matrix Summary (IMM V3 SAS)
Compliant (7009 requirements section) Areas of incomplete compliance (7009 requirements (reqs) 
section- # of reqs in given section out of total # of compliance incomplete reqs) 
Programmatics (4.1) Verification, validation, and uncertainty (4.4- 7 of 9 reqs) 
Models (4.2) Training (4.6- 2 of 9 reqs)  
Simulations and analyses (4.3) 
Assessing the credibility of M&S 
results (4.7) 
Reporting results to decision 
makers (4.8) 
IMM V&V Plan Summary (IMM V3 SAS) 
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IMM Element Internal Review % Complete External Review % Complete 
IMM list of medical conditions verification 
validation 
100  
100 
NASA 
non-NASA 
60 
0 
CliFF V&V process verification 
validation 
80  
80 
NASA or non-NASA 2 
CliFF content verification 
validation 
98  
98 
NASA 
non-NASA 
3* 
0   
External modules (conditional) verification 
validation 
50  
50 
NASA or non-NASA 50 
IMM overall approach verification 
validation 
80  
80 
NASA 
non-NASA 
80 
0   
Model programming verification 
validation 
100  
95 
non-NASA 0 
Software and code documentation verification 
validation 
90  
80 
non-NASA 0 
IMM database process verification 
validation 
20
20 
non-NASA 0
IMM output components verification 
validation 
94  
26 
NASA 5 
IMM output results validation 20 NASA 5 
*based on completion of 100 CliFFs 
IMM Credibility Scoring (IMM V3 SAS)
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Summary
• Early integration of credibility assessment as part of the IMM development 
and implementation process yielded: 
• Confidence in the IMM for customer and end user decision makers  
• Significant risk forecast contributions to operations, science and technology planning, 
and exploration research  
• ISS Program acceptance 
• Transition to operational model and simulation tool 
• Completion of service requests from broad end user consortium 
• Reporting tools have evolved over the lifetime of the IMM project to better 
communicate VV&C status 
• Comprehensive VV&C approach combining IMM V&V Plan with NASA-STD-7009 
requirements 
• Important to appropriately weight the different credibility assessment factors for the 
problem of interest  
• The greater medical community recognizes the importance of rigorously 
vetting computational models and looks to NASA for leadership 
 Getting It Right: Better Validation Key to 
Progress in Biomedical Computing - Bringing 
models closer to reality - 10/19/12 
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National Aeronautics and Space Administration National Aeronautics and Sp ce Administration 
Questions? 
For more information about how to apply the NASA-STD-7009 
to models and simulations: “How to Develop and Interpret Credibility 
Assessments of  Numerical Models for Human Research:  
NASA-STD-7009 Demystified” Thursday, February 13 2:20pm in 
Iris/Tulip 
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Comparison of IMM v3S and IMM v3M: ISS 6 Mission
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IMM V3S IMM V3M 
95% Confidence Interval   95% Confidence Interval 
Primary Output Component Mean/ 
Probability 
Lower Bound Upper Bound   Mean/ 
Probability 
Lower 
Bound 
Upper 
Bound 
Total Medical Events 105.63 87 125   105.66 87 125
CHI* 91.01 76.12 97.44   91.55* 75.81 98.07 
EVAC Probability  0.1123 0.1092 0.1154   0.1136 0.1107 0.1167 
LOCL Probability  0.0059 0.0051 0.0066   0.0058 0.0051 0.0066 
Treated CHI* 92.03 79.63 97.52   92.86* 80.25 98.15 
Untreated CHI* 16.02 2.44 32.51   17.44* 3.39 34.32 
Treated EVAC Probability 0.0473 0.0452 0.0494   0.0470 0.0450 0.0490 
Treated LOCL Probability 0.0053 0.0046 0.0061   0.0048 0.0041 0.0054 
ISS6 Mission – Comparison of main IMM output parameters 
IMM Conceptual Model (IMM V3 SAS) 
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IMM Conceptual Model Diagram
 FI’s (AMA Guidelines, 
Global Burden of 
Disease, SME)
 Duration (SME, 
Clinical Guidelines)
• Best Case
• Worst Case
• Untreated Case
• Probability 
Distributions
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 In-flight data
CliFF
IMM Background
– 100 specific medical conditions, including 10 space 
adaptation conditions 
– Developed using International Space Station (ISS) 
based medical capability 
– Assumes ISS operational environment 
– Bounds clinical outcome uncertainty  
• Best-case scenario 
• Worst-case scenario 
• Untreated-case scenarios 
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IMM Applicability 
• IMM within scope of NASA-Standard-7009 
• IMM is subject to 7009 compliance 
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Modeling & 
Simulation   
Results 
 Influence 
  
5: Controlling           
4: Significant       IMM     
3: Moderate           
2: Minor           
1: Negligible           
  IV: Negligible   III: Moderate   II: Critical   I: Catastrophic   
Decision Consequence   
  
Risk and Criticality Assessment Matrix for IMM 
The broad applications of IMM contribute to the risk and criticality 
assessment of IMM v3.0.  
IMM NASA-STD-7009 Risk Assessment
IMM Core Questions
• For a specified mission scenario: 
– What medical conditions are most likely to occur? 
– What medical resources are most likely to be utilized? 
– What is the probability of evacuation or loss of crew life due to medical events? 
– What is the expected crew functional impairment and what is the uncertainty 
range of that impairment due to medical events? 
– What are the optimal medical resources to minimize crew functional impairment 
and the probability of evacuation or loss of crew life? 
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IMM Practical Application
• Medical systems design & optimization (current) 
– In-flight medical systems and electronic health records 
– Develop design handbooks relating risk-mass-volume per DRM 
• Managing science and technology portfolios (current) 
– Use sensitivity analyses to align budgets with most influential risk drivers 
for an established set of design reference missions (DRM) 
• Communicating health risks to programs, international partners 
(current) 
– Risk of evacuation, risk of loss of crew life, crew certification 
• Establish training priorities respective to mission (future) 
– Use sensitivity analyses to align limited training hours with most 
influential risk drivers for a particular mission and crew 
• Requirements development (current) 
– Use quantifiable IMM risk analyses as rationale to requirements 
• Knowledge management (current) 
– Use IMM database and central library to manage (review, vet, update) 
organizational memory for every medical condition of interest 
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IMM Customer-defined 7009 Sufficiency Thresholds 
Medical Conditions in IMM by Category
Medical Illness 
Acute Chest Pain/Angina                 Dental Tooth Loss             Nosebleed (SAS) 
Acute Prostatitis                               Depression                        Otitis Externa 
Allergic Reaction                              Diarrhea                             Otitis Media 
Anaphylaxis                                      Eye Abrasion                     Pharyngitis 
Anxiety                                              Eye Corneal  Ulcer            Seizures 
Appendicitis                                      Eye Infection                      Sepsis 
Atrial Fibrillation                                Gastroenteritis                   Sinus Infection 
Back Pain (SAS)                               Glaucoma                          Skin Infection      
Behavioral Emergency                      Headache (SAS)               Skin Rash 
Cardiogenic Shock                            Hemorrhoid                       Space Motion Sickness (SAS) 
Choking (foreign body  inhalation)    Indigestion                         Stroke 
Constipation (SAS)                           Insomnia  (SAS)                 Sudden Cardiac Arrest 
Cough (URI/Pneumonia)                  Kidney Stones                    Urinary Incontinence  (SAS)    
Dental Abscess                                 Late Insomnia                    Urinary Retention  (SAS) 
Dental Crown Replacement              Medication OD/Misuse       Urinary Tract Infection 
Dental Temporary Filling                   Mouth Ulcer/Cold Sore       Vaginal Yeast Infection 
Dental Toothache                              Nasal Congestion (SAS) 
 
SAS = space adaptation syndrome  
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Medical Conditions in IMM by Category
Injury/Trauma:     Abdominal Injury 
           Back Injury 
           Chest Injury/Pneumothorax 
           Eye Abrasion 
           Eye Penetration 
           Elbow Dislocation 
           Finger Dislocation 
           Fingernail Delamination (EVA) 
           Head Injury (TBI) 
           Hip/Proximal Femur Fracture 
           Hypovolemic Shock 
           Lumbar Spine Fracture 
           Neck Injury 
           Neurogenic Shock 
           Paresthesias/Hot Spots (EVA) 
           Shoulder Dislocation 
           Skin Abrasion/Laceration 
           Sprain/Strain 
           Wrist Fracture 
 
  Environmental: 
            Acute Radiation Sickness 
            Altitude Sickness 
            Barotrauma (ear/sinus block) 
            Burns 
            Decompression Sickness (EVA) 
            Eye Chemical Burn 
            Headache (CO2 induced) 
            Smoke Inhalation 
            Toxic Exposure 
 
21 
Likelihood: IMM Evidence Base
• Only U.S. medical in-flight data used 
• Astronaut health information  
– published reference sources 
– lifetime surveillance of astronaut health (LSAH) database 
– medical records including flight surgeon interviews 
• ISS Expeditions 1 thru 13 (2006) 
• STS-01 through STS-114 (2005) 
• Apollo, Skylab, Mir (U.S. crew only) 
• Review of crew medical charts
• Flight surgeon subject matter expertise 
• Analog, terrestrial data 
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Plan for LSAH Validation Data Set 
